|
921 |
Oral Tau Aggregation Inhibitor for Alzheimer’s Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate Enthalten in The journal of prevention of Alzheimer's disease 26.6.2022: 1-11
|
|
|
922 |
The efficacy of a tart cherry drink for the treatment of patellofemoral pain in recreationally active individuals: a placebo randomized control trial Enthalten in Sport sciences for health 23.6.2022: 1-14
|
|
|
923 |
Evaluation of the efficacy of Thymus kotschyanus extract as an additive treatment in patients with ulcerative colitis: a randomized double-blind placebo-controlled trial Enthalten in Inflammopharmacology 20.6.2022: 1-8
|
|
|
924 |
Ruyi Zhenbao Pills for Patients with Motor and Sensory Dysfunction after Stroke: A Double-Blinded, Randomized Placebo-Controlled Clinical Trial Enthalten in Chinese journal of integrative medicine 20.6.2022: 1-7
|
|
|
925 |
Efficacy of subcutaneous semaglutide compared to placebo for weight loss in obese, non-diabetic adults: a systematic review & meta-analysis Enthalten in International journal of clinical pharmacy 17.6.2022: 1-8
|
|
|
926 |
Menthacarin for long-term treatment of functional dyspepsia – Results from a clinical trial follow-up Enthalten in Zeitschrift für Gastroenterologie 13.06.2022
|
|
|
927 |
Endoscopic Injections of Botulinum Toxin Type A in the Piglet Esophagus Is Safe and Feasible but Did Not Result in any Significant Structural Changes 3 Days after Injection Enthalten in European journal of pediatric surgery 10.06.2022
|
|
|
928 |
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children Enthalten in European archives of psychiatry and clinical neuroscience 7.6.2022: 1-15
|
|
|
929 |
A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial) Enthalten in Annals of surgical oncology 6.6.2022: 1-2
|
|
|
930 |
A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot Study Enthalten in Digital biomarkers Bd. 6, 2022, Nr. 1: 1-8. 8 S.
|
|